Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Taiwan / NCT07782047
Starting soon Observational

Assistive Device Rental/Purchase, LTC Service Use, and Caregiver Burden in Taiwan

NCT07782047 · tracked via the Priya Life Science Taiwan tracker
Phase
Observational
Started
2026-09-01
Last updated
2026-08-24

Condition(s) studied

Self-Help DevicesLong-Term CareCaregiver BurdenHealth Services Research

Study summary

The goal of this observational study is to examine the associations between assistive device approval and acquisition modality (rental or purchase), long-term care service utilization, and family caregiver burden among individuals receiving long-term care services in Taiwan. The study will use de-identified nationwide long-term care administrative data from 2021 to 2022.

The main questions it aims to answer are:

1. What individual, disability-related, socioeconomic, residential, and caregiving factors are associated with assistive device approval, the number and type of approved devices, and rental or purchase modality?
2. Are assistive device approval and utilization patterns associated with the use of formal long-term care services and with family caregiver burden?

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Individuals with a valid long-term care case record (CA100) in Taiwan's long-term care database between 2021 and 2022. * Individuals with at least one valid assessment or care plan record (CA110) that can be linked to the corresponding CA100 record. * Availability of interpretable key study variables, including individual and assessment/care plan identifiers, care plan status, and Case-Mix System (CMS) level or other core disability-related information. * For analyses of assistive device utilization, the presence or absence of an assistive device record (QD113) and its approval status must be identifiable. Exclusion Criteria: * Records with missing key linkage variables that prevent establishment of relationships among individuals, care plans, assistive device records, or service utilization records. * Records identified as invalid, cancelled, test records, or records whose validity cannot be determined. * Records in which primary study variables cannot be interpreted. * Records with clearly implausible values for variables such as individual age, caregiver age, CMS level, number of assistive devices, or service utilization that cannot be corrected according to prespecified data-cleaning rules. * Records with inconsistent or contradictory date information that prevents valid determination of an index date or observation period.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
National Center for Geriatrics and Welfare Research, National Health Research Institutes Huwei Yunlin County

More National Health Research Institutes, Taiwan trials in Taiwan

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07782047 on ClinicalTrials.gov ↗ ← All trials in Taiwan